Market Research Logo

South Africa Pharmaceuticals & Healthcare Q1 2019

South Africa Pharmaceuticals & Healthcare Q1 2019

Key View:

Despite the elevated risk profile for multinational drugmakers in South Africa, the country will remain the largest andmost developed in Sub-Saharan Africa, retaining its attractive status for innovative medicine launches. Nevertheless, South Africa’sconsiderable market size leaves it exposed to a number of external influences, both industry and macroeconomic related. Keydevelopments to watch over the near term include the impact of the reformed intellectual property policy on local and foreigndrugmakers, reforms to the National Health insurance Scheme and the ability of ‘South African Health Products RegulatoryAuthority’ to clear its pipeline of backlogged medicines.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Innovative Pharmaceuticals Risk/Reward Index
South Africa Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Adcock Ingram
Aspen Pharmacare
Cipla Medpro
GlaxoSmithKline
Novartis
Pfizer
Roche
Sanofi
South Africa Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report